John Robson is the CEO and Managing Director of BioOra, a New Zealand biotech company scaling automated CAR-T cell therapy manufacturing. He brings over two decades of deep-tech investment experience from his role at Bridgewest Ventures, and has been closely involved in early-stage life-science companies since 2008. As a board member of multiple biotech startups, Robson combines financial acumen, risk strategy, and vision to help BioOra deliver affordable, high-quality cell therapies.